Company: Nitto BioPharma Inc.
Job title: Chief Scientist
Panel Discussion: Setting Up Context: Capitalizing on the Current Wave of Inhaled Delivery 9:00 am
With renewed interest sparked by COVID-19, unmet clinical needs and better formulation technologies, inhaled delivery offers key advantages over other routes of administration for targeted local delivery. In this panel discussion, experts will explore: Reflecting on COVID-19, renewed interest and novel technologies Formulating biologics for inhaled delivery such as mRNA Discussing advantages of inhalation to…Read more
day: Conference Day 1